基于20-脱氧烯醇-的PKC激动剂及其溶酶体生物发生增强活性的设计
Jia-Jia Wan1,2,3, Qiu-Yuan Yin4, Mao Sun5
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China.
Natural products and bioprospecting
|June 10, 2025
概括
新化合物增强了自和溶酶体功能,这对于清除神经退行性疾病中的有毒蛋白质至关重要. 这些新型衍生物通过向蛋白激酶C三角酶 (PKCδ) 来显示出作为治疗剂的前景.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 蛋白激酶C (PKC) 的激活促进了溶酶生物发生,以清除神经退行性疾病中的Aβ和p-Tau等致病性聚合物.
- 新型PKC激活剂可能使用非正规机制,如在HEP14/15中所见,缺乏经典C1B域相互作用.
- 溶解体功能障碍与阿尔茨海默氏症和帕金森症等疾病中有毒蛋白质的积累有关.
研究的目的:
- 为了合成和选新型的20-脱氧醇衍生物,以促进溶酶体和诱导自的活性.
- 确定在增强自-溶解体系统方面具有优越功效的特定化合物.
- 阐明潜在的作用机制,包括PKC异型相互作用.
主要方法:
- 通过化和乙胺保护合成18种新的20-脱氧醇衍生物 (2-19).
- 系统查 lysosome促进和自诱导活动.
- 结构-活动关系分析,西部涂抹和分子对接模拟.
主要成果:
- 化合物4和18被确定为优越的自诱导剂,在20μM时增强自流量超过2.3倍.
- 这些化合物剂量依赖地增加了溶酶体数量,促进了TFEB核转位,并增强了脂滴清除.
- 西方斑点分析证实了自-溶酶体系统蛋白质的上调,分子对接表明高亲和力结合PKCδ.
结论:
- 新型20-脱氧醇衍生物,特别是化合物4和18是自和溶酶体生物发生的强有力的诱导剂.
- 这些化合物通过促进有毒蛋白质聚合物的清除来证明神经退行性疾病的治疗潜力.
- 该机制可能涉及PKCδ的非正规激活,导致增强自-溶酶体通路功能.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:31Lysosomes
16.9K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
16.9K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K